Clinical trial
Frequency of Elevated Fecal Calprotectin Levels in Psoriatic Arthritis and Its Predictive Role for Inflammatory Bowel Disease Occurrence: a Prospective, Long-term, Controlled Study.
NCT04190108 is registered in ClinicalTrials.gov with Hospital of Prato as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Frequency of Elevated Fecal Calprotectin Levels in Psoriatic Arthritis and Its Predictive Role for Inflammatory Bowel Disease Occurrence: a Prospective, Long-term, Controlled Study.
- Lead sponsor
- Hospital of Prato
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 2, 2016
- Completion date
- October 31, 2019
- Enrollment
- 259 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
inflammatory bowel diseases, psoriatic arthritis